{"id":164255,"date":"2022-12-08T00:13:53","date_gmt":"2022-12-08T05:13:53","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/kronos-bio-announces-selection-of-recommended-phase-2-dose-for-its-oral-cdk9-inhibitor-kb-0742-after-reaching-target-engagement-goal-with-acceptable\/"},"modified":"2024-08-18T11:45:47","modified_gmt":"2024-08-18T15:45:47","slug":"kronos-bio-announces-selection-of-recommended-phase-2-dose-for-its-oral-cdk9-inhibitor-kb-0742-after-reaching-target-engagement-goal-with-acceptable","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/kronos-bio-announces-selection-of-recommended-phase-2-dose-for-its-oral-cdk9-inhibitor-kb-0742-after-reaching-target-engagement-goal-with-acceptable.php","title":{"rendered":"Kronos Bio Announces Selection of Recommended Phase 2 Dose for its Oral CDK9 Inhibitor, KB-0742, After Reaching Target Engagement Goal with Acceptable&#8230;"},"content":{"rendered":"<p><![CDATA[Kronos Bio to move into Phase 2 stage of study, evaluating compound in patients with MYC-amplified and other transcriptionally addicted tumors]]><\/p>\n<p>Read the rest here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/12\/07\/2569721\/0\/en\/Kronos-Bio-Announces-Selection-of-Recommended-Phase-2-Dose-for-its-Oral-CDK9-Inhibitor-KB-0742-After-Reaching-Target-Engagement-Goal-with-Acceptable-Safety-Profile-in-Ongoing-Phase.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Kronos Bio Announces Selection of Recommended Phase 2 Dose for its Oral CDK9 Inhibitor, KB-0742, After Reaching Target Engagement Goal with Acceptable...\">Kronos Bio Announces Selection of Recommended Phase 2 Dose for its Oral CDK9 Inhibitor, KB-0742, After Reaching Target Engagement Goal with Acceptable...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the rest here: Kronos Bio Announces Selection of Recommended Phase 2 Dose for its Oral CDK9 Inhibitor, KB-0742, After Reaching Target Engagement Goal with Acceptable... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/kronos-bio-announces-selection-of-recommended-phase-2-dose-for-its-oral-cdk9-inhibitor-kb-0742-after-reaching-target-engagement-goal-with-acceptable.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-164255","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/164255"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=164255"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/164255\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=164255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=164255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=164255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}